IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young adults under the age of 50. It is a refractory brain cancer that is difficult ...

High-dose vitamin B3 is showing intriguing early promise as an addition to standard glioblastoma treatment, with 82% of ...

A rare and stubbornly difficult category of brain tumors has long forced adult patients and their physicians into an ...

Glioblastoma, the most common and most lethal adult brain malignancy, remains highly refractory to most treatment approaches.

Glioblastoma kills most patients within 15 months of diagnosis. It is the most aggressive brain cancer in young adults, and for decades, oncologists have treated it as a disease that seems to appear ...

For two decades, neurosurgeons have relied on glowing dyes to help them see the invisible margins of glioblastoma, the most ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. While rare, malignant brain tumors often have poor outcomes Nearly half of all malignant ...

Brain cancer is one of the deadliest diseases — and early detection is crucial for better outcomes. There are obvious symptoms like sudden, severe headaches and dizziness, while subtle signs such as ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the United States (U.S.) Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for ...

Researchers at Texas Children's Duncan Neurological Research Institute (Duncan NRI), Baylor College of Medicine and ...